Kerry has expanded its biotechnology manufacturing facility in Carrigaline, Co. Cork, enhancing its capacity to produce lactase enzymes for lactose-free and sugar-reduced dairy products. This investment aims to enable faster scale-up and consistent supply to support global dairy producers as demand grows. Kerry’s CEO highlights the facility’s role in bridging enzyme innovation and industrial production, allowing quicker market access for new products. The expansion strengthens Ireland’s position in advanced manufacturing and supports over 200 customers in more than 80 countries, processing over 2 million tonnes of milk annually and serving approximately 28 million consumers worldwide.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.foodengineeringmag.com/articles/103651-kerry-expands-biotechnology-manufacturing-facility-in-ireland
